Brett Sandercock - Jan 10, 2022 Form 4 Insider Report for RESMED INC (RMD)

Role
Chief Financial Officer
Signature
Brett Sandercock, Chief Financial Officer
Stock symbol
RMD
Transactions as of
Jan 10, 2022
Transactions value $
-$443,100
Form type
4
Date filed
1/11/2022, 04:18 PM
Previous filing
Dec 14, 2021
Next filing
Feb 14, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RMD ResMed Common Stock Options Exercise $144K +2.5K +2.35% $57.76 109K Jan 10, 2022 Direct F1
transaction RMD ResMed Common Stock Sale -$588K -2.5K -2.3% $235.00 106K Jan 10, 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction RMD ResMed Common Stock Options Options Exercise $0 -2.5K -12.5% $0.00 17.5K Jan 10, 2022 ResMed Common Stock 2.5K $57.76 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The transaction was conducted under a Rule 10b5-1 plan.
F2 Represents date options first became exercisable. Options vest 1/3 per year.